ATE465715T1 - Orales abgabesystem mit einem biliquid foam - Google Patents

Orales abgabesystem mit einem biliquid foam

Info

Publication number
ATE465715T1
ATE465715T1 AT04767956T AT04767956T ATE465715T1 AT E465715 T1 ATE465715 T1 AT E465715T1 AT 04767956 T AT04767956 T AT 04767956T AT 04767956 T AT04767956 T AT 04767956T AT E465715 T1 ATE465715 T1 AT E465715T1
Authority
AT
Austria
Prior art keywords
weight
biliquid foam
delivery system
oral delivery
pharmaceutically acceptable
Prior art date
Application number
AT04767956T
Other languages
English (en)
Inventor
William Charman
Monica Dias
Michelle Georgiou
Philip Guffogg
Christopher Porter
Colin Pouton
Fraser Steele
Derek Wheeler
Original Assignee
Drug Delivery Solutions Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Drug Delivery Solutions Ltd filed Critical Drug Delivery Solutions Ltd
Application granted granted Critical
Publication of ATE465715T1 publication Critical patent/ATE465715T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A61K9/122—Foams; Dry foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
AT04767956T 2003-07-30 2004-07-30 Orales abgabesystem mit einem biliquid foam ATE465715T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0317869.6A GB0317869D0 (en) 2003-07-30 2003-07-30 Improved drug delivery system
PCT/GB2004/003329 WO2005011628A2 (en) 2003-07-30 2004-07-30 Oral delivery system comprising a biliquid foam

Publications (1)

Publication Number Publication Date
ATE465715T1 true ATE465715T1 (de) 2010-05-15

Family

ID=27799499

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04767956T ATE465715T1 (de) 2003-07-30 2004-07-30 Orales abgabesystem mit einem biliquid foam

Country Status (14)

Country Link
US (1) US20060228408A1 (de)
EP (1) EP1653923B1 (de)
JP (1) JP4953815B2 (de)
CN (2) CN1832727A (de)
AT (1) ATE465715T1 (de)
AU (1) AU2004261053B2 (de)
CA (1) CA2533833C (de)
DE (1) DE602004026879D1 (de)
DK (1) DK1653923T3 (de)
ES (1) ES2344898T3 (de)
GB (1) GB0317869D0 (de)
RU (1) RU2353350C2 (de)
WO (1) WO2005011628A2 (de)
ZA (1) ZA200600761B (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0404403D0 (en) * 2004-02-27 2004-03-31 Disperse Ltd Dispersions
US10265265B2 (en) 2007-03-15 2019-04-23 Drug Delivery Solutions Limited Topical composition
GB0712389D0 (en) * 2007-06-26 2007-08-01 Drug Delivery Solutions Ltd A Pharmaceutical composition
EP2008651A1 (de) 2007-06-26 2008-12-31 Drug Delivery Solutions Limited Biologisch erodierbares Patch
CN101780037B (zh) * 2010-02-03 2011-11-16 南昌大学 双嘧达莫自乳化给药系统及其制备方法
GB201006218D0 (en) 2010-04-14 2010-06-02 Ayanda As Composition
BR112013023458B1 (pt) 2011-03-14 2020-04-07 Drug Delivery Solutions Ltd composição oftálmica, e, método para fabricar a composição oftálmica
CA3023121A1 (en) * 2011-04-11 2012-10-18 Vitux Group As Oral pharmaceutical dispersion compositions
EP3542788A1 (de) 2018-03-19 2019-09-25 MC2 Therapeutics Limited Topische zusammensetzung enthaltend calcipotriol und betamethason dipropionat

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4486333A (en) * 1981-04-10 1984-12-04 Felix Sebba Preparation of biliquid foam compositions
US4999198A (en) * 1989-03-23 1991-03-12 The Board Of Governors For Higher Education, State Of Rhode Island And Providence Plantations Polyaphrons as a drug delivery system
IL105553A (en) * 1992-05-06 1998-01-04 Janssen Pharmaceutica Inc Solid dosage form comprising a porous network of matrix forming material which disperses rapidly in water
US5840881A (en) * 1992-11-27 1998-11-24 Takeda Chemical Industries, Ltd. Composition containing a water-insoluble or slightly water-soluble compound with enhanced water-solubility
PT884995E (pt) * 1996-03-08 2002-11-29 Disperse Ltd Dispersoes incluindo uma espuma biliquida a base de oleo e um gel aquoso
NL1003503C2 (nl) * 1996-07-04 1998-01-07 Negma Steba International Dev Farmaceutische samenstelling voor orale toediening.
GB2326337A (en) * 1997-06-20 1998-12-23 Phares Pharma Holland Homogeneous lipid compositions for drug delivery
CA2368334C (en) * 2000-02-22 2010-04-20 Color Access, Inc. Acidic gelled aqueous cosmetic compositions comprising oil-containing biliquid foam dispersion
GB0214793D0 (en) * 2002-06-26 2002-08-07 Disperse Technologies Plc Biliquid foam entrapment

Also Published As

Publication number Publication date
CA2533833A1 (en) 2005-02-10
WO2005011628A2 (en) 2005-02-10
JP4953815B2 (ja) 2012-06-13
US20060228408A1 (en) 2006-10-12
EP1653923B1 (de) 2010-04-28
AU2004261053B2 (en) 2011-08-25
CA2533833C (en) 2013-05-28
GB0317869D0 (en) 2003-09-03
RU2353350C2 (ru) 2009-04-27
CN101579311B (zh) 2013-11-27
AU2004261053A1 (en) 2005-02-10
EP1653923A2 (de) 2006-05-10
DE602004026879D1 (de) 2010-06-10
WO2005011628A3 (en) 2005-05-06
CN1832727A (zh) 2006-09-13
ES2344898T3 (es) 2010-09-09
DK1653923T3 (da) 2010-08-09
RU2006106173A (ru) 2007-09-10
CN101579311A (zh) 2009-11-18
JP2007500181A (ja) 2007-01-11
ZA200600761B (en) 2007-05-30

Similar Documents

Publication Publication Date Title
WO2005115406A3 (en) 8-(2-hydroxyphenoxy)octyldiethanolamine and salts thereof for delivery of active agents
WO2005065317A3 (en) Effervescent oral fentanyl dosage form
NO20064670L (no) Galeniske formuleringer av organiske forbindelser
IT1318539B1 (it) Composizioni farmaceutiche a rilascio prolungato per lasomministrazione parenterale di sostanze idrofile biologicamente
WO2005065319A3 (en) Generally linear effervescent oral fentanyl dosage form and methods of administering
WO2006035417A3 (en) Dihydropyrimidine microcapsule - formulations
WO2008060934A8 (en) Formulations of tetrahydropyridine antiplatelet agents for parenteral or oral administration
BR0112311A (pt) Compostos e composições para liberar agentes ativos, forma de dosagem unitária, método para preparar ditas composições e seu uso
WO2002019969A3 (en) (5-(2-hydroxy-4-chlorobenzoyl) aminovaleric acid and salts thereof and compositions containing the same for delivering active agents
MXPA05008909A (es) Formulacion intranasal de rotigotina.
NO20082988L (no) Vedvarende frigivningsformulering innbefattende oktreotid og to eller flere polylaktid-ko-glykolidpolymerer
WO2007048219A3 (en) Sustained drug release composition
AR108594A2 (es) Formulaciones farmacéuticas que conservan el sabor con características farmacéuticas mejoradas
RU2350333C3 (ru) Применение ивермектина для лечения дерматологических расстройств
WO2008023016A3 (en) Galenic formulations of aliskiren
IL179718A0 (en) Pharmaceutical composition containing irbesartan
AR052252A1 (es) Formulaciones topicas de nepafenac
EP2279732A3 (de) Verbindungen und Zusammensetzungen zur Wirkstofffreisetzung
NO20062051L (no) Farmasoytisk virkestoffinneholdende formulering med belegg
DE602004026879D1 (de) Orales abgabesystem mit einem biliquid foam
WO2002015959A3 (en) Compounds and compositions for delivering active agents
EP1744767A4 (de) Therapeutisches abgabesystem mit peg-ähnlicher verbindung mit hohem molekulargewicht
EA200600953A1 (ru) Дозированные формы торсемида пролонгированного высвобождения
WO2002034240A3 (en) Delayed and sustained release formulations and method of use thereof
JP2007500181A5 (de)

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties